CN1144523A - 由阿罗地平的非对映的酒石酸盐分离其对映体 - Google Patents
由阿罗地平的非对映的酒石酸盐分离其对映体 Download PDFInfo
- Publication number
- CN1144523A CN1144523A CN95192238A CN95192238A CN1144523A CN 1144523 A CN1144523 A CN 1144523A CN 95192238 A CN95192238 A CN 95192238A CN 95192238 A CN95192238 A CN 95192238A CN 1144523 A CN1144523 A CN 1144523A
- Authority
- CN
- China
- Prior art keywords
- horizon
- dmso
- tartrate
- luo
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Abstract
Description
助溶剂 | 助溶剂的体积比(%) | 由HPLC测定的非对映体过量 |
水 | 0.25% | 96.8%de. |
水 | 0.5% | 87.7%de. |
丙酮 | 1% | 94%de. |
二甲基乙酰胺 | 1% | 89%de. |
甲基乙基酮 | 2% | 97%de. |
四氢呋喃 | 2% | 96.7%de. |
乙酸乙酯 | 2% | 90.4%de. |
二氯甲烷 | 2% | 93.2%de. |
二甲基甲酰胺 | 2% | 93.2%de. |
甲苯 | 2% | 72.3%de. |
丙酮 | 5% | 95%de. |
异丙醇 | 5% | 95%de. |
DMPU(见本文) | 5% | 96.6%de. |
二甲基甲酰胺 | 5% | 93.2%de. |
乙酸乙酯 | 5% | 79.2%de. |
二氯甲烷 | 5% | 74%de. |
丙酮 | 50% | 94%de. |
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9405833A GB9405833D0 (en) | 1994-03-24 | 1994-03-24 | Separation of the enantiomers of amlodipine |
GB9405833.6 | 1994-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1144523A true CN1144523A (zh) | 1997-03-05 |
CN1067055C CN1067055C (zh) | 2001-06-13 |
Family
ID=10752425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95192238A Expired - Fee Related CN1067055C (zh) | 1994-03-24 | 1995-03-06 | 由阿罗地平的非对映的酒石酸盐分离其对映体 |
Country Status (27)
Country | Link |
---|---|
US (2) | US5750707A (zh) |
EP (1) | EP0751938B1 (zh) |
JP (1) | JP2843681B2 (zh) |
KR (1) | KR100188980B1 (zh) |
CN (1) | CN1067055C (zh) |
AT (1) | ATE166050T1 (zh) |
AU (1) | AU677765B2 (zh) |
BR (1) | BR9507137A (zh) |
CA (1) | CA2186263C (zh) |
CO (1) | CO4230248A1 (zh) |
CZ (1) | CZ287324B6 (zh) |
DE (1) | DE69502486T2 (zh) |
DK (1) | DK0751938T3 (zh) |
ES (1) | ES2116737T3 (zh) |
FI (1) | FI113646B (zh) |
GB (1) | GB9405833D0 (zh) |
HU (1) | HU214720B (zh) |
IL (1) | IL113008A (zh) |
MY (1) | MY111979A (zh) |
NO (1) | NO306110B1 (zh) |
NZ (1) | NZ282404A (zh) |
PE (1) | PE48895A1 (zh) |
PL (1) | PL180085B1 (zh) |
RU (1) | RU2132845C1 (zh) |
TW (1) | TW448156B (zh) |
WO (1) | WO1995025722A1 (zh) |
ZA (1) | ZA952362B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060799A1 (fr) * | 2000-02-21 | 2001-08-23 | Xitian Zhang | Resolution d'enantiomeres d'amlidipine |
WO2003043989A1 (en) * | 2001-11-22 | 2003-05-30 | Xitian Zhang | Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions |
CN100364976C (zh) * | 2002-09-11 | 2008-01-30 | 韩林制药株式会社 | S-(-)-氨氯地平的制备方法 |
CN100436417C (zh) * | 2006-04-11 | 2008-11-26 | 石药集团中奇制药技术(石家庄)有限公司 | 一种光学活性氨氯地平的拆分方法 |
CN101316820B (zh) * | 2005-10-17 | 2012-03-07 | Sk化学株式会社 | 制备手性氨氯地平龙胆酸盐的方法 |
CN101495451B (zh) * | 2006-07-21 | 2012-07-25 | 韩美药品株式会社 | (s)-(-)-氨氯地平樟脑磺酸盐或其水合物及包含其的药物组合物 |
CN101528697B (zh) * | 2006-10-27 | 2013-02-13 | Cj第一制糖株式会社 | 从外消旋氨氯地平分离s-(-)-氨氯地平的方法 |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9317773D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
US20050158408A1 (en) * | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
US7772220B2 (en) * | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
US20070072828A1 (en) * | 1998-07-24 | 2007-03-29 | Yoo Seo H | Bile preparations for colorectal disorders |
US6333342B1 (en) * | 1998-11-04 | 2001-12-25 | Isotechnika, Inc | Methods of pharmacological treatment using S(−) amlodipine |
GB0020842D0 (en) * | 2000-08-23 | 2000-10-11 | Pfizer Ltd | Therapeutic compositions |
US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
EP1448527A1 (en) | 2001-10-24 | 2004-08-25 | Sepracor, Inc. | Method of resolving amlodipine racemate |
US20030176706A1 (en) * | 2002-03-18 | 2003-09-18 | Joshi Rohini Ramesh | Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate] |
EP1348697A1 (en) * | 2002-03-28 | 2003-10-01 | Council Of Scientific & Industrial Research | Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate |
US20040072879A1 (en) * | 2002-10-10 | 2004-04-15 | Dr. Reddy's Laboratories Limited | Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine) |
KR20120058618A (ko) * | 2003-01-31 | 2012-06-07 | 다이이찌 산쿄 가부시키가이샤 | 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약 |
US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
US6846932B1 (en) * | 2003-11-20 | 2005-01-25 | Council Of Scientific And Industrial Research | Process for preparation of chiral amlodipine salts |
BRPI0416648A2 (pt) * | 2003-11-20 | 2009-01-13 | Council Scient Ind Res | processo para a preparaÇço de sais quirais farmaceuticamente aceitÁveis de amlodipina |
CN1231469C (zh) | 2003-12-05 | 2005-12-14 | 石家庄制药集团欧意药业有限公司 | 一种光学活性氨氯地平的拆分方法 |
US20060030602A1 (en) * | 2004-03-16 | 2006-02-09 | Sepracor Inc. | (S)-amlodipine malate |
ES2339790T3 (es) * | 2004-08-30 | 2010-05-25 | Seo Hong Yoo | Efecto neuroprotector de udca solubilizado en modelo isquemico focal. |
ATE506955T1 (de) * | 2004-10-15 | 2011-05-15 | Seo Hong Yoo | Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin |
EP1802576B1 (en) * | 2004-10-20 | 2008-06-25 | Emcure Pharmaceuticals Limited | Process for producing enantiomer of amlodipine in high optical purity |
CA2585471A1 (en) * | 2004-11-01 | 2006-05-11 | Seo Hong Yoo | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
KR101152608B1 (ko) * | 2004-12-02 | 2012-06-07 | 에스케이케미칼주식회사 | (r,s)-암로디핀으로부터 암로디핀 이성질체의 분리방법 |
MX2007006663A (es) * | 2004-12-02 | 2012-10-05 | Sk Chemicals Co Ltd | Metodo para la separacion optica de amlodipina. |
HUP0500570A3 (en) * | 2005-06-08 | 2008-03-28 | Richter Gedeon Nyrt | Process for the preparation of (s)-(-)-amlodipine |
US20080279942A1 (en) * | 2005-06-27 | 2008-11-13 | Takeshi Hamaura | Pharmaceutical Preparation Containing an Angiotensin II Receptor Antagonist and a Calcium Channel Blocker |
TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
KR100830003B1 (ko) * | 2006-10-31 | 2008-05-15 | 씨제이제일제당 (주) | 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법 |
KR100868160B1 (ko) | 2007-02-14 | 2008-11-12 | 한미약품 주식회사 | S-(-)-암로디핀 또는 이의 염의 제조방법 및 이에사용되는 중간체 |
KR100979772B1 (ko) | 2008-06-12 | 2010-09-02 | 에이치 엘 지노믹스(주) | 광학적으로 순수한 에스-(-)-암로디핀 벤젠술폰산염의제조방법 |
KR100989970B1 (ko) | 2008-07-01 | 2010-10-26 | 미래파인켐 주식회사 | (s)-(-)-암로디핀의 분리방법 |
KR101085169B1 (ko) | 2009-03-25 | 2011-11-18 | (주)켐트로스 | 암로디핀 광학 이성질체의 분리방법 |
KR101705535B1 (ko) * | 2009-04-01 | 2017-02-28 | 주식회사 씨트리 | 광학활성을 갖는 1-(3-히드록시페닐)에틸아민의 제조방법 |
RU2537361C1 (ru) * | 2013-07-18 | 2015-01-10 | Общество С Ограниченной Ответственностью "Синтегал" | Оптические изомеры (+) и (-)-бензгидрилмочевин и (+) и (-)-1-[(3-хлорфенил)-фенил-метил]мочевины, фармацевтическая композиция на их основе и способ их получения |
CN110882249B (zh) | 2019-11-08 | 2021-04-30 | 北京吾为尔创科技有限公司 | 含苯磺酸左氨氯地平水合物的组合物及其制备方法 |
CN111100064B (zh) * | 2020-01-08 | 2024-01-02 | 湖南理工学院 | 一种从废液中富集、回收和拆分碱性手性药物氨氯地平的方法 |
CN111777547B (zh) * | 2020-07-17 | 2021-10-08 | 江西施美药业股份有限公司 | 一种诱导析晶拆分左旋氨氯地平的方法 |
US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364872A (en) * | 1984-04-16 | 1994-11-15 | Yamanouchi Pharmaceutical Co., Ltd. | Dihydropyridine-3,5-dicarboxylic acid ester derivatives |
GR850872B (zh) * | 1984-04-16 | 1985-11-25 | Yamanouchi Pharma Co Ltd | |
US5326772A (en) * | 1984-09-28 | 1994-07-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Diaryl compounds for their use |
CH669788A5 (zh) * | 1985-08-21 | 1989-04-14 | Glaxo Spa | |
DK142287A (da) * | 1986-03-27 | 1987-09-28 | Byk Gulden Lomberg Chem Fab | Optisk aktive 1,4-dihydropyridinderivater |
NZ220022A (en) * | 1986-04-22 | 1990-04-26 | Byk Gulden Lomberg Chem Fab | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
JPH03500647A (ja) * | 1987-10-27 | 1991-02-14 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 新規ピロリジン |
GB8804630D0 (en) * | 1988-02-27 | 1988-03-30 | Pfizer Ltd | Preparation of r-& s-amlodipine |
GB8822170D0 (en) * | 1988-09-21 | 1988-10-26 | Pfizer Ltd | Therapeutic agents |
IT1230752B (it) * | 1989-02-17 | 1991-10-29 | Boehringer Biochemia Srl | Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. |
DE3906460C1 (zh) * | 1989-03-01 | 1990-11-15 | Goedecke Ag, 1000 Berlin, De |
-
1994
- 1994-03-24 GB GB9405833A patent/GB9405833D0/en active Pending
-
1995
- 1995-02-08 TW TW084101060A patent/TW448156B/zh not_active IP Right Cessation
- 1995-03-06 DK DK95912222T patent/DK0751938T3/da active
- 1995-03-06 CN CN95192238A patent/CN1067055C/zh not_active Expired - Fee Related
- 1995-03-06 ES ES95912222T patent/ES2116737T3/es not_active Expired - Lifetime
- 1995-03-06 EP EP95912222A patent/EP0751938B1/en not_active Expired - Lifetime
- 1995-03-06 CZ CZ19962784A patent/CZ287324B6/cs not_active IP Right Cessation
- 1995-03-06 PL PL95316535A patent/PL180085B1/pl not_active IP Right Cessation
- 1995-03-06 RU RU96119351A patent/RU2132845C1/ru not_active IP Right Cessation
- 1995-03-06 US US08/704,612 patent/US5750707A/en not_active Expired - Fee Related
- 1995-03-06 NZ NZ282404A patent/NZ282404A/en unknown
- 1995-03-06 BR BR9507137A patent/BR9507137A/pt not_active IP Right Cessation
- 1995-03-06 DE DE69502486T patent/DE69502486T2/de not_active Expired - Fee Related
- 1995-03-06 KR KR1019960705266A patent/KR100188980B1/ko not_active IP Right Cessation
- 1995-03-06 CA CA002186263A patent/CA2186263C/en not_active Expired - Fee Related
- 1995-03-06 AT AT95912222T patent/ATE166050T1/de not_active IP Right Cessation
- 1995-03-06 HU HU9602597A patent/HU214720B/hu not_active IP Right Cessation
- 1995-03-06 WO PCT/EP1995/000847 patent/WO1995025722A1/en active IP Right Grant
- 1995-03-06 JP JP7524336A patent/JP2843681B2/ja not_active Expired - Fee Related
- 1995-03-06 AU AU19493/95A patent/AU677765B2/en not_active Ceased
- 1995-03-13 CO CO95009744A patent/CO4230248A1/es unknown
- 1995-03-16 IL IL11300895A patent/IL113008A/xx not_active IP Right Cessation
- 1995-03-16 PE PE1995264250A patent/PE48895A1/es not_active Application Discontinuation
- 1995-03-20 MY MYPI95000696A patent/MY111979A/en unknown
- 1995-03-23 ZA ZA952362A patent/ZA952362B/xx unknown
-
1996
- 1996-09-23 FI FI963775A patent/FI113646B/fi active
- 1996-09-23 NO NO963991A patent/NO306110B1/no unknown
-
1998
- 1998-05-05 US US09/071,810 patent/US6046338A/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060799A1 (fr) * | 2000-02-21 | 2001-08-23 | Xitian Zhang | Resolution d'enantiomeres d'amlidipine |
CN1100038C (zh) * | 2000-02-21 | 2003-01-29 | 张喜田 | 氨氯地平对映体的拆分 |
US6646131B2 (en) | 2000-02-21 | 2003-11-11 | Xitian Zhang | Resolution of the enantiomers of amlodipine |
WO2003043989A1 (en) * | 2001-11-22 | 2003-05-30 | Xitian Zhang | Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions |
CN100364976C (zh) * | 2002-09-11 | 2008-01-30 | 韩林制药株式会社 | S-(-)-氨氯地平的制备方法 |
CN101316820B (zh) * | 2005-10-17 | 2012-03-07 | Sk化学株式会社 | 制备手性氨氯地平龙胆酸盐的方法 |
CN100436417C (zh) * | 2006-04-11 | 2008-11-26 | 石药集团中奇制药技术(石家庄)有限公司 | 一种光学活性氨氯地平的拆分方法 |
CN101495451B (zh) * | 2006-07-21 | 2012-07-25 | 韩美药品株式会社 | (s)-(-)-氨氯地平樟脑磺酸盐或其水合物及包含其的药物组合物 |
CN101528697B (zh) * | 2006-10-27 | 2013-02-13 | Cj第一制糖株式会社 | 从外消旋氨氯地平分离s-(-)-氨氯地平的方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1067055C (zh) | 由阿罗地平的非对映的酒石酸盐分离其对映体 | |
CN1100038C (zh) | 氨氯地平对映体的拆分 | |
EP1831166B1 (en) | Optical resolution method of amlodipine | |
US7202365B2 (en) | Processes for the preparation of S-(-)-amlodipine | |
EP2077993B1 (en) | Method for the separation of s-(-)-amlodipine from racemic amlodipine | |
EP0488345B1 (en) | Optically active 1,4-Dihydropyridine derivatives and methods of producing the same | |
KR101125123B1 (ko) | 높은 광학적 순도의 s-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물 | |
KR101152608B1 (ko) | (r,s)-암로디핀으로부터 암로디핀 이성질체의 분리방법 | |
CN1231469C (zh) | 一种光学活性氨氯地平的拆分方法 | |
KR100760014B1 (ko) | 암로디핀의 광학 분리방법 | |
EP0385423B1 (de) | Verfahren zur Herstellung der optischen Isomeren von 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure-ethyl-ester und 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure- 2-(N-methyl-N-phenylmethylamino)ethyl ester | |
EP0628538B1 (de) | Verfahren zur acylierung von Threonin-Derivaten und deren Verwendung zur Herstellung von 1,4-Dihydropyridinen | |
CN101209991A (zh) | 制备s-(-)-氨氯地平的方法 | |
MXPA96004299A (en) | Separation of amlodypine binders by means of their diastereoisome tartrates | |
JPH07165715A (ja) | ジヒドロピリジン化合物およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: PFIZER(IRELAND) PHARMACEUTICALS CO.,LTD. Free format text: FORMER OWNER: PFIZER(WARNER-LAMBERT) INTERNATIONAL FINANCE CO., LTD. Effective date: 20060811 Owner name: PFIZER(IRELAND) PHARMACEUTICALS CO.,LTD. Free format text: FORMER OWNER: PFIZER(WARNER-LAMBERT) OVERSEA PHARMACY CO.,LTD. Effective date: 20060811 Owner name: PFIZER(WARNER-LAMBERT) INTERNATIONAL FINANCE CO., Free format text: FORMER OWNER: PFIZER RESEARCH AND DEVELOPMENT COMPANY Effective date: 20060811 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: PFIZER(WARNER-LAMBERT) OVERSEA PHARMACY CO.,LTD. Free format text: FORMER NAME OR ADDRESS: PFIZER(IRELAND) PHARMACEUTICALS CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Dublin, Ireland Patentee after: Pfizer Overseas Pharmaceutical Co. Address before: Dublin, Ireland Patentee before: PFIZER IRELAND PHARMACEUTICALS |
|
TR01 | Transfer of patent right |
Effective date of registration: 20060811 Address after: Dublin, Ireland Patentee after: Pfizer International Finance Ltd. Address before: Dublin, Ireland Patentee before: Pfizer Inc. |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |